CWK director converts 17,013 RSUs to shares

Cushman & Wakefield Ltd. director Jennifer J. McPeek reported routine equity compensation activity.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Cushman & Wakefield Ltd. director Jennifer J. McPeek reported routine equity compensation activity. On May 15, 2026, previously awarded restricted stock units (RSUs) covering 17,013 common shares converted into the same number of common shares without any cash changing hands, under the company’s non‑employee director incentive plan.

Separately, on May 14, 2026, she received a new grant of 14,041 RSUs, which are scheduled to vest and settle on May 14, 2027, generally conditioned on her continued board service. Following these transactions, she directly holds 35,516 common shares.

Insider Trade Summary

17,013 shares exercised/converted

Exercise 3 txns

Insider McPeek Jennifer J

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	17,013	$0.00	$0.00
Exercise	Common Shares	17,013	$0.00	$0.00
Grant/Award	Restricted Stock Units	14,041	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 14,041 contracts (Direct); Common Shares — 35,516 shares (Direct)

Footnotes (4)

F1. Conversion of previously awarded restricted stock units ("RSUs") into an equal number of common shares, without the payment of any consideration, pursuant to the Third Amended & Restated 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan.
F2. RSUs granted under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan convert into an equal number of common shares of Cushman & Wakefield Ltd. without the payment of any consideration.
F3. RSUs were granted on May 14, 2026 and vest and settle on May 14, 2027 subject, with certain limited exceptions, to the reporting person's continuing board service through such vesting date.
F4. RSUs were granted on May 15, 2025 and vested and settled on May 15, 2026.

Key Figures

RSUs converted: 17,013 shares New RSU grant: 14,041 RSUs Common shares held: 35,516 shares +2 more

5 metrics

RSUs converted 17,013 shares RSUs converted into common shares on May 15, 2026

New RSU grant 14,041 RSUs Grant date May 14, 2026; vesting May 14, 2027

Common shares held 35,516 shares Direct holdings after transactions

Exercise/Conversion price $0.00 per share RSUs convert to common shares without consideration

Prior RSU grant vesting May 15, 2026 RSUs granted May 15, 2025 vested and settled on this date

Key Terms

Restricted Stock Units, Exercise or conversion of derivative security, Grant, award, or other acquisition, Omnibus Share and Cash Incentive Plan

4 terms

Restricted Stock Units financial

"RSUs granted under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan convert into an equal number of common shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Jennifer McPeek report for Cushman & Wakefield (CWK)?

Jennifer McPeek reported the conversion of 17,013 previously awarded RSUs into common shares and a new grant of 14,041 RSUs. These actions reflect routine director equity compensation, with no open-market purchases or sales disclosed in this Form 4.

How many Cushman & Wakefield (CWK) shares did Jennifer McPeek acquire in this Form 4?

She acquired 17,013 common shares through the conversion of an equal number of restricted stock units. The conversion occurred without payment of consideration, pursuant to Cushman & Wakefield’s non-employee director share and cash incentive plan.

How many restricted stock units were granted to Jennifer McPeek at Cushman & Wakefield (CWK)?

She received a grant of 14,041 restricted stock units on May 14, 2026. These RSUs convert into the same number of common shares and are scheduled to vest and settle on May 14, 2027, generally subject to her continued board service.

Did Jennifer McPeek sell any Cushman & Wakefield (CWK) shares in this filing?

No sales were reported. The Form 4 only shows an RSU-to-share conversion of 17,013 common shares and a separate award of 14,041 RSUs, with no open-market or other share dispositions disclosed in the provided data.

How many Cushman & Wakefield (CWK) shares does Jennifer McPeek hold after these transactions?

After the RSU conversion, she directly holds 35,516 common shares. This total reflects her position following the issuance of 17,013 common shares in exchange for previously awarded restricted stock units reported in the filing.

When do Jennifer McPeek’s new Cushman & Wakefield (CWK) RSUs vest?

The 14,041 restricted stock units granted on May 14, 2026 vest and settle on May 14, 2027. Vesting is generally conditioned on her continuing to serve on Cushman & Wakefield’s board through that vesting date, subject to limited exceptions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/18/2026 - 05:31 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McPeek Jennifer J

(Last)

(First)

(Middle)

225 WEST WACKER DRIVE

(Street)

CHICAGO

ILLINOIS

60606

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cushman & Wakefield Ltd. [ CWK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	05/15/2026		M		17,013	A	⁽¹⁾	35,516	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	05/14/2026		A		14,041		⁽³⁾	⁽³⁾	Common Shares	14,041	$0	14,041	D
Restricted Stock Units	⁽¹⁾	05/15/2026		M			17,013	⁽⁴⁾	⁽⁴⁾	Common Shares	17,013	$0	0	D

Explanation of Responses:

1. Conversion of previously awarded restricted stock units ("RSUs") into an equal number of common shares, without the payment of any consideration, pursuant to the Third Amended & Restated 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan.

2. RSUs granted under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan convert into an equal number of common shares of Cushman & Wakefield Ltd. without the payment of any consideration.

3. RSUs were granted on May 14, 2026 and vest and settle on May 14, 2027 subject, with certain limited exceptions, to the reporting person's continuing board service through such vesting date.

4. RSUs were granted on May 15, 2025 and vested and settled on May 15, 2026.

Remarks:

	/s/ Noelle J. Perkins, attorney-in-fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR